{"transactions":[{"id":4623706,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:05:24.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":6850,"price":3.2364,"value":22169.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":17269,"source":{"system":"sec-edgar","filing":"0001193125-26-396894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526396894/ownership.xml","form_type":"4"}},{"id":4623705,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:05:24.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":4909,"price":3.3183,"value":16289.5347,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24119,"source":{"system":"sec-edgar","filing":"0001193125-26-396894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526396894/ownership.xml","form_type":"4"}},{"id":4623704,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:05:24.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1417,"price":3.774,"value":5347.758,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29028,"source":{"system":"sec-edgar","filing":"0001193125-26-396894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526396894/ownership.xml","form_type":"4"}},{"id":4623703,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":4077,"price":3.2364,"value":13194.8028,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":17082,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623702,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":2922,"price":3.3183,"value":9696.0726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21159,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623701,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":843,"price":3.774,"value":3181.482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24081,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623700,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":509,"price":3.876,"value":1972.884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":1924,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623697,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":9132,"price":3.2364,"value":29554.8048,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":25384,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623696,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":6545,"price":3.3183,"value":21718.2735,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34516,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623695,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1889,"price":3.774,"value":7129.086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41061,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623694,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":637,"price":3.876,"value":2469.012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":2950,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":741684,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:15:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526267560/ownership.xml","form_type":"4"}},{"id":742429,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:14:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312526267558/ownership.xml","form_type":"4"}},{"id":741683,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:12:02.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526267546/ownership.xml","form_type":"4"}},{"id":741682,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:10:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526267533/ownership.xml","form_type":"4"}},{"id":741681,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:07:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526267518/ownership.xml","form_type":"4"}},{"id":919381,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-04T21:32:18.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026."}],"balance_after":10000,"derivative":{"exercise_price":6.71,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-037692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526037692/ownership.xml","form_type":"4"}},{"id":919447,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-04T16:32:38.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":6.71,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-037697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526037697/ownership.xml","form_type":"4"}},{"id":919446,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-02-04T16:32:38.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":4.607,"value":575.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":2313,"source":{"system":"sec-edgar","filing":"0001193125-26-037697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526037697/ownership.xml","form_type":"4"}},{"id":919703,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-04T16:32:00.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026."}],"balance_after":8000,"derivative":{"exercise_price":6.71,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-037690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526037690/ownership.xml","form_type":"4"}},{"id":919702,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-02-04T16:32:00.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":4.607,"value":575.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan , in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":1415,"source":{"system":"sec-edgar","filing":"0001193125-26-037690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526037690/ownership.xml","form_type":"4"}},{"id":967543,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967542,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967541,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.02,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967540,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":1000,"derivative":{"exercise_price":5.44,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967539,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":849,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.596,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":849},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967538,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":849,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":849,"derivative":{"exercise_price":5.44,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":849},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967537,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following September 3, 2024; provided, however that the option will vest in full upon a change in control."}],"balance_after":0,"derivative":{"exercise_price":13.596,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967536,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":21169,"kind":"person","name":"Dupont Jakob","position":1,"cik":"0001553335","reported_name":"Dupont Jakob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following September 3, 2024; provided, however that the option will vest in full upon a change in control."}],"balance_after":2500,"derivative":{"exercise_price":5.44,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-25-321156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321156/ownership.xml","form_type":"4"}},{"id":967535,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director  Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967534,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director  Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967533,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.364,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967532,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967531,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967530,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967529,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":39.8,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967528,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967527,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":60.6,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":611},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967526,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":611,"derivative":{"exercise_price":5.44,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":611},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967525,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":60.6,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967524,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1107,"derivative":{"exercise_price":5.44,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967523,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":83.8,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967522,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39270,"kind":"person","name":"ONETTO NICOLE","position":1,"cik":"0001220049","reported_name":"ONETTO NICOLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:38.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1393,"derivative":{"exercise_price":5.44,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321154/ownership.xml","form_type":"4"}},{"id":967521,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967520,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967519,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.364,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967518,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967517,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967516,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967515,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":613,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.2,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":613},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967514,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":613,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":613,"derivative":{"exercise_price":5.44,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":613},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967513,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of December 14, 2022 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":27.2,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":967512,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39272,"kind":"person","name":"Berner Laura","position":1,"cik":"0001958382","reported_name":"Berner Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:14:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of December 14, 2022 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":2500,"derivative":{"exercise_price":5.44,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-25-321153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321153/ownership.xml","form_type":"4"}},{"id":968568,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968567,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968566,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.364,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968565,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968564,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968563,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968562,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.2,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968561,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on December 14, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968560,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":39.8,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968559,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968558,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":60.6,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968557,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968556,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 29, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":88.2,"expiration_date":"2030-12-28","underlying":"Common Stock","underlying_shares":1392},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":968555,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":29393,"kind":"person","name":"LAPORTE KATHLEEN","position":1,"cik":"0001196201","reported_name":"LAPORTE KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:46.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on December 29, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1392,"derivative":{"exercise_price":5.44,"expiration_date":"2030-12-28","underlying":"Common Stock","underlying_shares":1392},"source":{"system":"sec-edgar","filing":"0001193125-25-321152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196201/000119312525321152/ownership.xml","form_type":"4"}},{"id":967511,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967510,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967509,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.364,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967508,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967507,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967506,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967505,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":39.8,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967504,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967503,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":60.6,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1810},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967502,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1810,"derivative":{"exercise_price":5.44,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1810},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967501,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on November 17, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":180.2,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967500,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on November 17, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1393,"derivative":{"exercise_price":5.44,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967499,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.02,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":17499},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967498,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":17499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":17499,"derivative":{"exercise_price":5.44,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":17499},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967497,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":0,"derivative":{"exercise_price":14.602,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":7749},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967496,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":7749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":7749,"derivative":{"exercise_price":5.44,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":7749},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967495,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":25.4,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":11749},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967494,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":11749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":11749,"derivative":{"exercise_price":5.44,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":11749},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967493,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11399,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on February 27, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2033-02-26","underlying":"Common Stock","underlying_shares":11399},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967492,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":11399,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on February 27, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":11399,"derivative":{"exercise_price":5.44,"expiration_date":"2033-02-26","underlying":"Common Stock","underlying_shares":11399},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967491,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":61.6,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":9499},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967490,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":9499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":9499,"derivative":{"exercise_price":5.44,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":9499},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967489,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":400,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":4999},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967488,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":4999,"derivative":{"exercise_price":5.44,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":4999},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967487,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":86.8,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967486,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":2142,"derivative":{"exercise_price":5.44,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967485,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4642,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on November 13, 2019, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":54.6,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":4642},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967484,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4642,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on November 13, 2019, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":4642,"derivative":{"exercise_price":5.44,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":4642},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967483,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on January 11, 2019, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":44.8,"expiration_date":"2029-01-10","underlying":"Common Stock","underlying_shares":1653},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967482,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on January 11, 2019, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1653,"derivative":{"exercise_price":5.44,"expiration_date":"2029-01-10","underlying":"Common Stock","underlying_shares":1653},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967481,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on April 4, 2018, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":40.6,"expiration_date":"2028-04-03","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967480,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on April 4, 2018, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":822,"derivative":{"exercise_price":5.44,"expiration_date":"2028-04-03","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}},{"id":967479,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67746,"kind":"person","name":"Yonehiro Grant","position":1,"cik":"0001428666","reported_name":"Yonehiro Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T22:11:55.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agree to cancellation of an option granted on January 17, 2018, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":40.6,"expiration_date":"2028-01-17","underlying":"Common Stock","underlying_shares":660},"source":{"system":"sec-edgar","filing":"0001193125-25-321148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321148/ownership.xml","form_type":"4"}}],"next_cursor":"2025-12-16T22:11:55.000000Z,967479"}